Established · publishing since 1969
Prostate Cancer Diagnosis and TreatmentBladder and Urothelial Cancer TreatmentsProstate Cancer Treatment and ResearchEconomic and Financial Impacts of CancerUrinary Tract Infections Management
Publications
377
Citations
3,981
Est. group size
—
Recurring co-author estimate
Active years
58
Publishing since 1969
In context
Among 4,953 established Medicine PIs within our index
Citations: 3,981p25 789 · p75 7,423 · cohort median 2,544
Publications / year (recent): 22.8p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~8 · 10% small-team papers (≤3 authors) · across 48 venues
Publication cadence
Publications per year over the last 10 years — averaging 22.8/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Editorial Comment: Serum Albumin Levels Are Independently Associated With Length of Stay and Readmission in Patients With Renal Cell Carcinoma
JU Open Plus · 2026
- Differences in Bladder Cancer Diagnosis by Demographic Factors: A Simulation Modeling Analysis
medRxiv · 2026
- Editorial Comment: The Number of Cancer-Involved Regions in Patients With Prostate Cancer Diagnosed by Magnetic Resonance Imaging/Ultrasound-Guided Fusion Prostate Biopsy Is a New Tumor Metric Associated With the Increased Risk of Adverse Pathology at Radical Prostatectomy
JU Open Plus · 2026
- Impacts of a Rural Hospital Global Budget Alternative Payment Model on Patterns of Cancer Surgery
Medical Care · 2026
- Supplementary Figure S5 from Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer
2026
- Supplementary Figure S1 from Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer
2026
- Supplementary Figure S2 from Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer
2026
- Supplementary Figure S4 from Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer
2026
- Data from Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer
2026
- Supplementary Table S1 from Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer
2026
- Supplementary Figure S3 from Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer
2026
- Treatment Patterns for Non-muscle Invasive Bladder Cancer During the Bacillus Calmette-Guerin Shortage
Urology · 2025
- Bladder Cancer Burden in the USA: Population Scenarios for 2040
European Urology Open Science · 2025
- A Qualitative Analysis of Telemedicine Use Among Urban and Rural Patients With Urologic Malignancies
JU Open Plus · 2025
- Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States
Value in Health · 2025
Publishes in
- The Journal of Urology×82
- Urology×40
- Urologic Oncology Seminars and Original Investigations×21
- JU Open Plus×13
- Urology Practice×10
Similar researchers
By research-topic overlap
- Brent K. Hollenbeck
Medicine · University of Michigan
- Rodney L. Dunn
Medicine · University of Michigan
- James E. Montie
Medicine · University of Michigan
- Patrick Lewicki
Medicine · University of Michigan
- Tudor Borza
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile